|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,395.50 GBX | -0.68% |
|
+0.40% | +3.64% |
| 07-07 | GSK plc completed the acquisition of Efimosfermin alfa drug from Boston Pharmaceuticals Inc. | CI |
| 07-07 | Sector Update: Health Care Stocks Weaker Late Afternoon | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Neutral |
| Resistance | 1,483.5 | 1,558.5 | 1,657 |
| Spread/Res. | -5.93% | -10.46% | -15.78% |
| Spread/Supp. | +0.40% | +10.40% | +7.84% |
| Support | 1,390 | 1,264 | 1,294 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- GSK Stock
- Charts GSK plc
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition